Yeah, hard to imagine them actually admitting that they just got it wrong. But it does seem that way. Surely even purely from an insurance point of view it is cheaper to pay for a CxBladder test rather than the full invasive work up? Not to mention better for the patients (although I doubt this is much of a concern for them)
As you say, let's see. But it's certainly better to be supported by the urologists than not.
Positive support from US Urological societies., page-3
Add PEB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $66.57M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 122 | 8.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.12pm 28/08/2024 (20 minute delay) ? |
| PEB (ASX) Chart |
Day chart unavailable